Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice

by Nathalie I. Bouwer, Agnes Jager, Crista Liesting, Marcel J.M. Kofflard, Jasper J. Brugts, Jos J.E.M. Kitzen, Eric Boersma, Mark-David Levin
Published 2020-08-01

NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab

by Nathalie I. Bouwer, Crista Liesting, Marcel J. M. Kofflard, Sylvia M. Sprangers-van Campen, Jasper J. Brugts, Jos J. E. M. Kitzen, Michael A. Fouraux, Mark-David Levin, Eric Boersma
Published 2019-05-01

Effectiveness of a hospital-based work support intervention for female cancer patients - a multi-centre randomised controlled trial.

by Sietske J Tamminga, Jos H A M Verbeek, Monique M E M Bos, Guus Fons, Jos J E M Kitzen, Peter W Plaisier, Monique H W Frings-Dresen, Angela G E M de Boer
Published 2013-01-01